Salix LLC Sustainability Profile
Salix LLC, a prominent player in the biotechnology industry, is headquartered in the United States and operates extensively across North America and Europe. Founded in 2001, the company has established itself as a leader in developing innovative therapies for gastrointestinal diseases, particularly focusing on conditions like irritable bowel syndrome and inflammatory bowel disease. Salix is renowned for its unique portfolio of prescription medications, including the well-regarded Xifaxan, which has transformed treatment protocols in its field. The company’s commitment to research and development has led to significant milestones, including numerous FDA approvals that underscore its market position. With a strong emphasis on patient-centric solutions, Salix LLC continues to make strides in improving the quality of life for individuals suffering from complex gastrointestinal disorders.
DitchCarbon Score
How does Salix LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Meat and Poultry industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Salix LLC's score of 7 is lower than 51% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Salix LLC, headquartered in the US, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. The company is part of a corporate family that includes Spectrum Brands Holdings, Inc., from which it inherits emissions data and climate commitments. However, no specific reduction targets or initiatives have been outlined for Salix LLC. As a merged entity, Salix LLC's climate commitments may align with those of Spectrum Brands Holdings, Inc., but specific details regarding emissions reduction targets or strategies are not available. The lack of reported emissions data suggests that Salix LLC is in the early stages of establishing its own climate strategy or may rely on the broader corporate initiatives of its parent company. In summary, while Salix LLC is part of a larger corporate structure with potential climate commitments, it currently lacks specific emissions data and reduction targets.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|
| Scope 1 | - | - | - | - | - | - | - | - |
| Scope 2 | - | - | - | - | - | - | - | - |
| Scope 3 | - | 000,000,000 | 00,000,000 | 00,000,000 | - | - | 0,000,000,000 | 0,000,000,000 |
How Carbon Intensive is Salix LLC's Industry?
How Carbon Intensive is Salix LLC's Location?
Salix LLC's Scope 3 Categories Breakdown
Salix LLC's Scope 3 emissions, which increased by 36% last year and increased significantly since 2017, demonstrating supply chain emissions tracking. Their carbon footprint includes supplier sustainability and value chain emissions data across Scope 3 categories, with "Purchased Goods and Services" being the largest emissions source at 83% of Scope 3 emissions.
Top Scope 3 Categories
Salix LLC's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Salix LLC has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
